Robert Dee Etherington
Chief Executive Officer bij CLENE INC.
Vermogen: 40 082 $ op 31-03-2024
Profiel
Robert Dee Etherington is currently the President, Chief Executive Officer & Director at Clene Nanomedicine, Inc. and Clene, Inc. He is also a Director at BioUtah and Corsair LLC.
Previously, he worked as the Marketing Director at Actelion Pharmaceuticals Ltd.
from 2000 to 2013.
Mr. Etherington completed his undergraduate degree at Brigham Young University in 1990 and obtained an MBA in 1992.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CLENE INC
0.07% | 29-06-2023 | 94 310 ( 0.07% ) | 40 082 $ | 31-03-2024 |
Actieve functies van Robert Dee Etherington
| Bedrijven | Functie | Begin |
|---|---|---|
| CLENE INC. | Chief Executive Officer | 01-04-2013 |
| BioUtah | Director/Board Member | 01-06-2016 |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Chief Executive Officer | 01-04-2013 |
| Corsair LLC | Director/Board Member | 01-03-2018 |
Eerdere bekende functies van Robert Dee Etherington
| Bedrijven | Functie | Einde |
|---|---|---|
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Sales & Marketing | 01-03-2013 |
Opleiding van Robert Dee Etherington
| Brigham Young University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The private company is based in Allschwil, Switzerland. | Health Technology |
| Corsair LLC |
